Clinical Inertia in the Treatment of Diabetes Presented by Matt Strum, Pharm D

Clinical Inertia in the Treatment of Diabetes

Presented by Matt Strum, Pharm D

Clinical inertia, in patients with type 2 diabetes, is defined as the delay in treatment initiation or intensification, despite suboptimal diabetes control. Tight glycemic control, particularly from onset and diagnosis, leads to significant reductions in microvascular and macrovascular complications.

Dr. Matt Strum, a Pharm D with NovoNordisk, will discuss and compare current ADA and AACE guidelines to review recommendations for increasing therapy and using insulin when appropriate.

 LIMITED TO METROCARE PROVIDERS WHO TREAT DIABETES

This program is targeted for clinicians (NPs, PAs, and RNs) as well as interested MDs/DOs involved in ordering/prescribing for diabetics.

Date/Time:  5:30 PM

Location:     Coletta’s Restaurant

                      2850 Appling Road

                      Memphis, TN 38018

RSVP to  by Tuesday, August 29

so that we may reserve your dinner.

For more information:   Donna Pendergrass  

                                       901.261.7796

                                       This email address is being protected from spambots. You need JavaScript enabled to view it.